載入...

Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate.

The Sheffield Trophoblastic Disease Centre treats about 25 patients with persistent trophoblastic disease each year. A total of 75% of patients are classified as low risk according to the Charing Cross Hospital prognostic scoring system and receive methotrexate (MTX) 50 mg, i.m., on days 1, 3, 5, 7...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Gillespie, A. M., Lorigan, P. C., Radstone, C. R., Waterhouse, J. C., Coleman, R. E., Hancock, B. W.
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 1997
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2228140/
https://ncbi.nlm.nih.gov/pubmed/9374387
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!